Tourette Syndrome and Other Tic Disorders, Diagnosis, Pathophysiology, and Treatment
Medicine 70:15-32, Singer,H.S.&Walkup,J.T., 1991
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Cholinergic Vesicular Transporters in Progressive Supranuclesar Palsy
Neurol 58:1013-1018,997, Suzuki,M.,et al, 2002
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Pharmacotherapy of Aphasia:A Critical Review
Stroke 25:1282-1289, Small,S.L., 1994
Extracellular Hippocampal Glutamate and Spontaneous Seizure in the Conscious Human Brain
Lancet 341:1607-1610, 16271993., During,M.J.&Spencer,D.D., 1993
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Age-Associated Memory Impairment:A Role for Catecholamines
Neurol 40:526-530, McEntee,W.J.&Crook,T.H., 1990
Restorative Neurology, Drugs and Recovery Following Stroke
Stroke 21:1636-1640, Goldstein,L.B.&Davis,J.N., 1990
The Brain in Schizophrenia
JNNP 53:725-726, Ron,M.A.&Harvey,I., 1990
Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
Neural Transplantation:Scientific Gains & Clinical Perspectives
Neurol 36:389-392, Fishman,P.S., 1986
Huntington's Disease, Pathogenesis & Management
NEJM 315:1267-1276, Martin,J.B.&Gusella,J.F., 1986
The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986
Cerebrospinal Fluid:A Selective Review
Ann Neurol 11; 1-101982., Cutler,R.W.P.,et al, 1982
Neurotransmitters & CNS Disease, The Future
Lancet 2:1381-1385, Bloom,F.E., 1982
Brain Peptides
(part I & II) NEJM 304:876-885, 944-951., Krieger,D.T.&Martin,J.G., 1981
Presynaptic Dopaminergic Deficits in Lesch-Nyhan Disease
NEJM 334:1568-1572, 16021996., Ernst,M.,et al, 1996
Schizophrenia as a Brain Disease, The Dopamine Receptor Story
Arch Neurol 50:1093-1095, 10971993., Seeman,P., 1993
Multistate Outbreak of Poisonings Associated with Illicit Use of Gamma Hydroxy Butyrate
JAMA 265:447-448, , 1991
Clinical, Path, & Neurochem Changes in Dementia:Subgroup with Preserved Mental Status & Neocortical Plaques
Ann Neurol 23:138-144, Katzman,R.,et al, 1988
Alcoholic Dementia:A Hypothesis
Lancet 1:1184-1186, Lishman,W.A., 1986
Neurochemical Studies of Early Onset Alzheimer's Disease, Possible Influence on Treatment
NEJM 313:7-11, Francis,P.T.,et al, 1985
Neurotransmitters & CNS Disease, Basal Ganglia Disease
Lancet 2:1141-1147, Marsden,C.D., 1982
Neurotransmitters & CNS Disease, Dementia
Lancet 2:1200-1204, Rossor,M.N., 1982
Reduced Dopamine-beta-hydroxylase Activity in Alzheimer's Disease
BMJ 282:93-94, Cross,A.J.,et al, 1981
Biochemical Evidence Of Dysfunction Of Brain Neurotransmitters In The Lesch-Nyhan Syndrome
NEJM 305:1106-1111, Lloyd,K.G.,et al, 1981
Alzheimer's Disease
Editorial, BMJ 281:1374-13751980., , 1980
Glycine Encephalopathy
NEJM 298:687, Ch'ien,L.T., 1978
Huntington's Chorea, Changes in Neurotransmitter Receptors in the Brain
NEJM 294:1305, Enna,S.J.,et al, 1976